164 related articles for article (PubMed ID: 23641703)
1. Prevalence and factors associated with probable HIV dementia in an African population: a cross-sectional study of an HIV/AIDS clinic population.
Nakku J; Kinyanda E; Hoskins S
BMC Psychiatry; 2013 May; 13():126. PubMed ID: 23641703
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
Njamnshi AK; Bissek AC; Ongolo-Zogo P; Tabah EN; Lekoubou AZ; Yepnjio FN; Fonsah JY; Kuate CT; Angwafor SA; Dema F; Njamnshi DM; Kouanfack C; Djientcheu Vde P; Muna WF; Kanmogne GD
J Neurol Sci; 2009 Oct; 285(1-2):149-53. PubMed ID: 19631349
[TBL] [Abstract][Full Text] [Related]
4. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.
Cross S; Önen N; Gase A; Overton ET; Ances BM
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1114-22. PubMed ID: 24114509
[TBL] [Abstract][Full Text] [Related]
5. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.
Nakasujja N; Skolasky RL; Musisi S; Allebeck P; Robertson K; Ronald A; Katabira E; Clifford DB; Sacktor N
BMC Psychiatry; 2010 Jun; 10():44. PubMed ID: 20537129
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Disorders in HIV-positive Patients.
Padole PS; Padhiyar RN; Yadav DS; Chavan SA
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
[TBL] [Abstract][Full Text] [Related]
7. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
8. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska J
AIDS Behav; 2012 Aug; 16(6):1464-71. PubMed ID: 22001934
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
Troncoso FT; Conterno Lde O
Rev Soc Bras Med Trop; 2015; 48(4):390-8. PubMed ID: 26312927
[TBL] [Abstract][Full Text] [Related]
10. Limitations of the International HIV Dementia Scale in the current era.
Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V;
AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293
[TBL] [Abstract][Full Text] [Related]
11. Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.
Nakimuli-Mpungu E; Mutamba B; Othengo M; Musisi S
Afr Health Sci; 2009 Aug; 9 Suppl 1(Suppl 1):S2-7. PubMed ID: 20589156
[TBL] [Abstract][Full Text] [Related]
12. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Risk Factors of HIV-Associated Neurocognitive Disorders in Rural Southwestern Uganda.
Namagga JK; Rukundo GZ; Voss JG
J Assoc Nurses AIDS Care; 2019; 30(5):531-538. PubMed ID: 31461736
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.
Atashili J; Gaynes BN; Pence BW; Tayong G; Kats D; O'donnell JK; Ndumbe PM; Njamnshi AK
BMC Neurol; 2013 Jul; 13():86. PubMed ID: 23855622
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and characteristics of suicidality in HIV/AIDS as seen in an African population in Entebbe district, Uganda.
Kinyanda E; Hoskins S; Nakku J; Nawaz S; Patel V
BMC Psychiatry; 2012 Jun; 12():63. PubMed ID: 22713589
[TBL] [Abstract][Full Text] [Related]
16. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
[TBL] [Abstract][Full Text] [Related]
17. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.
Lopardo GD; Bissio E; Iannella Mdel C; Crespo AD; Garone DB; Cassetti LI
J Acquir Immune Defic Syndr; 2009 Dec; 52(4):488-92. PubMed ID: 19654553
[TBL] [Abstract][Full Text] [Related]
18. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting.
Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ
AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734
[TBL] [Abstract][Full Text] [Related]
19. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.
Welch K; Morse A;
AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639
[TBL] [Abstract][Full Text] [Related]
20. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
